PMC:7274950 / 2325-2484 JSONTXT

Annnotations TAB JSON ListView MergeView

Two preparations of enzyme replacement therapy (ERT) -agalsidase alfa and agalsidase beta- with recombinant α-galactosidase was approved in Europe in 2001 [5].